NeuBase Therapeutics, Inc. NBSE
0.38 +0.38
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Sep 30, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 | FY 2019 Sep 30, 2019 | FY 2018 Sep 30, 2018 |
|---|---|---|---|---|---|
| -33.32M | -26.57M | -17.07M | -25.51M | -15.13M | |
| -33.78M | -25.41M | -17.38M | -26.13M | -13.24M | |
| -20.80 | -18.60 | -17.80 | -63.20 | -92.00 |
Balance sheet
| Fiscal year | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 | FY 2019 Sep 30, 2019 | FY 2018 Sep 30, 2018 |
|---|---|---|---|---|---|
| 23.15M | 52.89M | 31.99M | 10.31M | 249.60K | |
| 32.69M | 64.17M | 34.44M | 12.53M | 249.60K | |
| 9.50M | 10.10M | 3.15M | 2.50M | 291.50K | |
| 6.00M | 6.54M | 138.56K | 122.92K | 250.00K | |
| 23.19M | 54.07M | 31.29M | 10.03M | -41.90K |
Cash flow
| Fiscal year | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 | FY 2019 Sep 30, 2019 | FY 2018 Sep 30, 2018 |
|---|---|---|---|---|---|
| -29.01M | -18.87M | -10.71M | -2.85M | -9.49M | |
| -471.74K | -2.56M | -716.82K | -685.23K | 528.04K | |
| -257.02K | 42.34M | 33.11M | 13.60M | -86.26K | |
| -471.71K | -1.44M | -716.82K | -455.20K | 528.04K | |
| -29.74M | 20.90M | 21.68M | 10.06M | -9.05M |